New Ray Medicine International Holding Limited (NEW RAY MEDIC; stock code: 06108) announced its monthly return for the period ended 31 January 2026. The total authorized share capital remained at 15,000,000,000 ordinary shares with a par value of HKD 0.01, amounting to HKD 150,000,000. The number of issued shares stood at 200,616,665, and there were no treasury shares for the period under review.

The announcement confirms compliance with the applicable public float requirement. Additionally, the share option scheme adopted on 25 October 2013 continued with 12,820,000 options outstanding. No new ordinary shares were issued pursuant to these options during January 2026.